Do you want to read an article? Please log in or register.
Using Induction Chemoimmunotherapy as a Bridge to Definitive Local Therapy for Non-Metastatic NSCLC: Real-World Outcomes From a Comprehensive Cancer Center
Lung Cancer
Related content
Lung Cancer
Real-World Outcomes of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Single-Center Study
J Clin Med
Koren E, Yaacov A, Zidan J, C Roisman L, Peled N, Asna N
doi: 10.3390/jcm15124757
RECOMMENDED
Lung Cancer
Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
J Clin Med
Veccia A, D'Argento E, Morgillo F, Pizzutilo EG, Vitiello F, Pavan A, Lombardo F, Russano M, Morabito A, Gariazzo E, Genova C, Chiari R, Cristofano A, Delconte A, Vattemi E, Dessi A, Galanti D, Busato S, Palazzolo G, Savastano C, Azzarello G, Verderame F, Mazzi C, Bencardino D, Dipasquale M, Scala A, Della Corte CM, Piscazzi D, Gilli M, Bria E, Caffo O, Gori S, Inno A
doi: 10.3390/jcm15031165
RECOMMENDED
Lung Cancer
Real-world outcomes versus clinical trial results of first-line immunotherapy with or without chemotherapy in patients with metastatic non-small-cell lung cancer: the CORRELATE study
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
ESMO Open
Peters S, Salomonsen RJ, Diaz Perez I, Shcherbakova T, Wang A, Cai L, Sadow S, Liu SV
doi: 10.1016/j.esmoop.2025.106031
Lung Cancer
Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC: A Real-World Analysis Using a Nationwide Claims Database in Japan
Clin Lung Cancer
Takeda K, Yamamoto T, Umezawa R, Takahashi N, Okuda S, Jingu K
doi: 10.1016/j.cllc.2026.05.010
Lung Cancer
Real-world comparative effectiveness of sotorasib versus docetaxel monotherapy in second line and beyond for advanced or metastatic non-small cell lung cancer: A national database analysis from England
Lung Cancer
Karim N, Arnold K, Summers Y, Akram T, Trankov N, Vladimirova A, Chopra D, Mesa-Frias M, Waterhouse D, Stollenwerk B
doi: 10.1016/j.lungcan.2026.109469
RECOMMENDED
Lung Cancer
Impact of First-Line Maintenance Immunotherapy With or Without Pemetrexed for Non-Squamous Advanced/Metastatic Non-Small Cell Lung Cancer Lacking Targetable Mutations: A Real-World Analysis in England
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
Clin Lung Cancer
Gomes F, Gilding N, Tan V, Christoforou K, Rule J, Aziez A, Januszewski A, Minchom A
doi: 10.1016/j.cllc.2025.12.007
RECOMMENDED
Lung Cancer
Real-world outcomes of stage III NSCLCs managed by surgery or definitive radiation therapy in the era of immunotherapy
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
Eur J Surg Oncol
Abdelnour-Berchtold E, Chriqui LE, Zermatten L, Papadopoulos S, Forster C, Hasenauer A, Bedat B, Zellweger M, Kinj R, Mederos N, Christodoulou M, Addeo A, Triponez F, Karenovics W, Gonzalez M, Krueger T, Peters S, Bouchaab H, Perentes JY
doi: 10.1016/j.ejso.2026.111401
Lung Cancer
Multicenter Real-World Data on First-Line Chemoimmunotherapy in Patients With Advanced Non-Small Cell Lung Cancer and Performance Status 2: WJOG18424L
Clin Lung Cancer
Kataoka S, Shukuya T, Ohtsu H, Miyawaki T, Fujimoto D, Hayashi H, Toi Y, Yokoyama T, Kato T, Yamaguchi T, Tanaka K, Miura S, Tamiya M, Tachihara M, Otsubo K, Sato Y, Ikeda S, Sakata S, Masuda T, Takemoto S, Yamamoto N, Okamoto I, Takahashi K
doi: 10.1016/j.cllc.2025.12.002
Lung Cancer
Associated factors regarding systemic anticancer therapy use prior to death among patients with metastatic non-small cell lung cancer: A multicentre retrospective cohort study
Lung Cancer
Mokkenstorm K, van Beusekom S, Breukhoven C, Veldman A, Pustjens S, Dijkstra N, Bos-Gerkema M, Kunst P, Smit A, Geerse O, Santeon VBHC lung cancer group
doi: 10.1016/j.lungcan.2026.109551